tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Turning Point Therapeutics's activity chart (see below) currently has 86 price targets and 69 ratings on display.
Analysts average stock forecasts to be materialized ratio is 60.85% with an average time for these price targets to be met of 82.78 days.
Most recent stock forecast was given by from LEERINK on 13-Jun-2022.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-May-2020
$76
$-0.01 (-0.01%)
$101
4 years 1 months 1 days ago
(13-Jun-2022)
3/4 (75%)
$1.72 (2.32%)
42
Buy Since 26-May-2020
$76
$-0.01 (-0.01%)
4 years 1 months 8 days ago
(06-Jun-2022)
5/8 (62.5%)
$1.25 (1.67%)
55
Buy Since 10-Sep-2019
$76
$-0.01 (-0.01%)
$61
4 years 1 months 11 days ago
(03-Jun-2022)
4/4 (100%)
$1.41 (1.89%)
73
Hold Since 29-Sep-2021
$45
$-31.01 (-40.80%)
$53
4 years 4 months 13 days ago
(01-Mar-2022)
3/3 (100%)
$14.21 (46.15%)
197
Buy Since 13-May-2019
$85
$8.99 (11.83%)
$120
4 years 5 months 4 days ago
(10-Feb-2022)
4/6 (66.67%)
$49.25 (137.76%)
99
What is TPTX (Turning Point Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on TPTX (Turning Point Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TPTX (Turning Point Therapeutics)?
Which analyst is the currently most bullish on TPTX (Turning Point Therapeutics)?
Which analyst is the currently most reserved on TPTX (Turning Point Therapeutics)?
